← All trials
NCT01773018
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2012
- Primary completion
- Dec 1, 2015
- Completion date
- May 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 47
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Hutchison MediPharmaLead sponsor
- Monash UniversityCollaborator
- University of MelbourneOverall official - principal investigator
- University of WashingtonOverall official - principal investigator
- Monash UniversityOverall official - principal investigator
- University of MelbourneCollaborator
- University of Western AustraliaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.